Inpatient Glucose Management: Part 2
ADA and Joint Commission Guidelines for Best Practices
In part 1 of this series, we explained the risks and complications associated with inpatient glucose control. We learned that occurrences include hyperglycemia, hypoglycemia, poor treatment and/or lack of control, and hospital-acquired conditions.
The American Diabetes Association (ADA) and The Joint Commission have created recommendations for diabetes care in the hospital. Some of the best practices include:
- Insulin – The preferred method of glycemic control in the hospital setting.
- Sliding scale – This retrospective method of insulin dosing is strongly discouraged in the hospital setting as the sole method of treatment.
- Glucose range – Once insulin therapy begins, a target glucose range of 140-180 mg/dL (7.8-10.0 mmol/L) is recommended for most critically ill and non-critically ill patients.
- Stringent targets – The target range of 110-140 mg/dL is appropriate for select critically ill patients without increasing the risk of hypoglycemia.
In part 3 of this series, we will uncover the facts behind the positive outcomes of inpatient glucose control.
Related posts

Blog
Behind the Yellow Vests: My Experience Supporting Temple Health’s Success Reducing Hypoglycemia 2-3x
Behind the Yellow Vests: My Experience Supporting Temple Health’s Success Reducing Hypoglycemia 2-3x
As a Customer Success Manager of EndoTool, I've had the privilege of working with healthcare systems that are deeply committed to improving patient outcomes. Temple Health is one of those organizations. Their system-wide rollout of EndoTool SubQ wasn't just an ...

News
Monarch Medical Technologies Joins Glooko to Advance Connected Diabetes Care
Monarch Medical Technologies Joins Glooko to Advance Connected Diabetes Care
We are excited to announce that Monarch Medical Technologies, the creator of EndoTool® Glucose Management System, has been acquired by Glooko, a global leader in diabetes management solutions. For EndoTool customers, nothing changes in the care and support you receive. ...

Blog
5 Tips to Build a Winning Business Case for Patient-Specific Insulin Dosing Software
5 Tips to Build a Winning Business Case for Patient-Specific Insulin Dosing Software
When clinicians ask me, "How do we move beyond standard insulin protocols and implement a glycemic management software solution without getting stuck in committee?" My answer is simple: pair clinical impact with financial clarity. Below are five practical tips I've ...
Get in Touch
Ready to get started?
Fill in your details and one of our friendly team members will be in touch to show you how easily EndoTool can support your hospital.
"*" indicates required fields